SCHEMBL4339183

SCHEMBL4339183

COc1c(C(=O)NCc2ccco2)ccc2[nH]nc(-c3cccc(F)c3)c12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.48
GAA P10253 2/20 0.44
KDM4E B2RXH2 2/20 0.44
MAPK8 P45983 1/20 0.44
ALDH1A1 P00352 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
TSHR P16473 3/20 0.43
MAPK1 P28482 1/20 0.43
MAPT P10636 3/20 0.42
POLB P06746 1/20 0.42
HSD17B10 Q99714 3/20 0.42
NPSR1 Q6W5P4 3/20 0.42
USP2 O75604 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
NTRK1 P04629 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4341196 0.86 MEN1 (0.49) HPGDGAAKDM4EMAPK8ALDH1A1
SCHEMBL4329145 0.83 HPGD (0.48) HPGDGAAKDM4EMAPK8ALDH1A1
SCHEMBL2864651 0.83 APEX1 (0.52) HPGDKDM4EALDH1A1SMN1; SMN2MAPT
SCHEMBL5030011 0.83 HPGD (0.45) HPGDGAAKDM4EALDH1A1SMN1; SMN2
SCHEMBL4343211 0.83 MAP4K4 (0.45) MAPK8MAPTNTRK1
SCHEMBL4338790 0.82 RECQL (0.48) GAAKDM4EALDH1A1L3MBTL1TSHR
SCHEMBL4328143 0.80 HPGD (0.53) HPGDGAAKDM4EMAPK8ALDH1A1
SCHEMBL4343252 0.80 HSD17B10 (0.49) HPGDGAAKDM4EALDH1A1SMN1; SMN2
SCHEMBL6426341 0.79 KDM4E (0.47) HPGDGAAKDM4EALDH1A1SMN1; SMN2
SCHEMBL4340981 0.79 HPGD (0.52) HPGDGAAKDM4EMAPK8ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 HPGD 1817/4885GAA 4805/4885KDM4E 2531/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 HPGD 1817/4885GAA 4805/4885KDM4E 2531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.